Ametros said it expanded its drug monitoring program to track the use of controlled substances on Medicare Set-Asides it administers, following new guidance from the Centers for Medicare and Medicaid Services.
CMS recently updated Version 3.0 of its Workers’ Compensation Medicare Set-Aside Arrangement Reference Guide to “highly recommend” professional administration in cases where a claimant is taking opioids, benzodiazepines and other “frequently abused drugs.”
Ametros said it expanded its drug monitoring program protocol, incorporating new recommendations so the program now:
Ametros provides pharmacy discounts and clinical management services as part of its CareGuard program for its members, who are patients with medical settlements resulting from personal injuries.
May 5-8, 2024
Amplify Your Impact There’s no limit to what you can achieve when you join the global risk managem …
May 13-15, 2024
Join us May 13–15, 2024, for NCCI's Annual Insights Symposium (AIS) 2024, the industry’s premier e …
May 13-14, 2024
The Board of Managers is excited to announce that the CSIA 2024 Annual Meeting and Educational Con …
No Comments
Log in to post a comment